{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:15:33Z","timestamp":1789060533455,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jsat.2022.108851","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T01:09:42Z","timestamp":1659143382000},"page":"108851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Use of long-acting injectable buprenorphine in the correctional setting"],"prefix":"10.1016","volume":"142","author":[{"given":"Rosemarie A.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah D.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jsat.2022.108851_bb0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1016\/j.jsat.2022.108851_bb0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2022.108851_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","article-title":"A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release","volume":"184","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108851_bb0020","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/PPA.S311674","article-title":"Factors of interest in extended-release buprenorphine: Comparisons between incarcerated and non-incarcerated patients with opioid use disorder","volume":"15","author":"Chappuy","year":"2021","journal-title":"Patient Preference and Adherence"},{"issue":"10","key":"10.1016\/j.jsat.2022.108851_bb0025","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2105\/AJPH.2018.304666","article-title":"The first comprehensive program for opioid use disorder in a US statewide correctional system","volume":"108","author":"Clarke","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2022.108851_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"9","key":"10.1016\/j.jsat.2022.108851_bb0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2018.10136","article-title":"Real-world evidence and real-world data for evaluating drug safety and effectiveness","volume":"320","author":"Corrigan-Curay","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2022.108851_bb0040","first-page":"1","article-title":"Extended-release buprenorphine outcomes among treatment resistant veterans","author":"Cotton","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2022.108851_bb0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2015.03.003","article-title":"Extended-release naltrexone for alcohol and opioid problems in Missouri parolees and probationers","volume":"56","author":"Crits-Christoph","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2022.108851_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10550880902772373","article-title":"Medicaid coverage, methadone maintenance, and felony arrests: Outcomes of opiate treatment in two states","volume":"28","author":"Deck","year":"2009","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2022.108851_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2022.108851_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2022.108851_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst. Abus."},{"key":"10.1016\/j.jsat.2022.108851_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108241","article-title":"A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail","volume":"128","author":"Gordon","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2022.108851_bb0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"10173","key":"10.1016\/j.jsat.2022.108851_bb0080","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"393","author":"Haight","year":"2019","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.jsat.2022.108851_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.23032","article-title":"Comparison of treatment retention of adults with opioid addiction managed with extended-release buprenorphine vs daily sublingual buprenorphine-naloxone at time of release from jail","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Network Open"},{"issue":"10118","key":"10.1016\/j.jsat.2022.108851_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.jsat.2022.108851_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.9041","article-title":"Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine","volume":"4","author":"Lintzeris","year":"2021","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.jsat.2022.108851_bb0100","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamainternmed.2018.1052","article-title":"Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder","volume":"178","author":"Lofwall","year":"2018","journal-title":"JAMA Internal Medicine"},{"issue":"oct03 3","key":"10.1016\/j.jsat.2022.108851_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","volume":"345","author":"Macarthur","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2022.108851_bb0110","series-title":"A public health guide to ending the opioid epidemic","article-title":"Collaborating to address substance use disorder in correctional settings: The Rhode Island Experience","author":"Martin","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2022.108851_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2022.108851_bb0120","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences","year":"2019"},{"key":"10.1016\/j.jsat.2022.108851_bb0125","author":"NIDA"},{"key":"10.1016\/j.jsat.2022.108851_bb0130","author":"Project"},{"issue":"9991","key":"10.1016\/j.jsat.2022.108851_bb0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.jsat.2022.108851_bb0140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamapsychiatry.2020.1689","article-title":"Predictive modeling of opioid overdose using linked statewide medical and criminal justice data","volume":"77","author":"Saloner","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2022.108851_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s40352-021-00143-9","article-title":"The impact of the opioid crisis on U.S. State prison systems","volume":"9","author":"Scott","year":"2021","journal-title":"Health & Justice"},{"issue":"23","key":"10.1016\/j.jsat.2022.108851_bb0150","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence \u2014 What is it and what can it tell Us?","volume":"375","author":"Sherman","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2022.108851_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nature Reviews Disease Primers"},{"issue":"2","key":"10.1016\/j.jsat.2022.108851_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/picr.PICR_36_18","article-title":"Real world evidence (RWE) - Are we (RWE) ready?","volume":"9","author":"Suvarna","year":"2018","journal-title":"Perspectives in Clinical Research"},{"issue":"1","key":"10.1016\/j.jsat.2022.108851_bb0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: Development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jsat.2022.108851_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108389","article-title":"Long-acting buprenorphine vs. Naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)","volume":"128","author":"Waddell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108851_bb0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2147\/CEOR.S256714","article-title":"OUD care service improvement with prolonged-release buprenorphine in prisons","volume":"12","author":"Wright","year":"2020","journal-title":"Cost Estimation Analysis ClinicoEconomics and Outcomes Research"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:53Z","timestamp":1760039873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0740547222001337"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108851","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of long-acting injectable buprenorphine in the correctional setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108851"}}